460
Participants
Start Date
November 14, 2024
Primary Completion Date
August 31, 2028
Study Completion Date
August 31, 2028
SIM0270
Experimental
Everolimus (Afinitor®)
Experimental and Active comparator
Exemestane tablets
Active Comparator
Fulvestrant injection
Active Comparator
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
The First Affiliated Hispital of Bengbu Medical University, Bengbu
RECRUITING
Anhui Provincial Cancer Hospital, Hefei
RECRUITING
The First Affiliated Hispital of Anhui Medical University, Hefei
RECRUITING
Maanshan People's Hospital, Maanshan
RECRUITING
Beijing Cancer Hospital, Beijing
RECRUITING
The First Medical Center of PLA Ggeneral Hospital, Beijing
RECRUITING
The First Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
The Second Affiliated Hospital of Chongqing Medical University, Chongqing
RECRUITING
Fujian Cancer Hospital, Fuzhou
RECRUITING
Fujian Provincial Hospital, Fuzhou
NOT_YET_RECRUITING
The Second Affiliated Hospital of Fujian Medical University, Quanzhou
RECRUITING
Gansu Provincial Cancer Hospital, Lanzhou
RECRUITING
Guangdong Maternal and Child Health Hospital, Guangzhou
RECRUITING
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
Zhongshan City People's Hospital, Zhongshan
RECRUITING
Guangxi Medical University Cancer hospital, Nanning
RECRUITING
First Hospital Of Qinhuangdao, Qinhuangdao
RECRUITING
The Fourth Hospital of Hebei Medical University, Shijiazhuang
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Anyang Tumor Hospital, Anyang
RECRUITING
The First Affiliated Hospital of Henan University of Science & Technology, Luoyang
RECRUITING
The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou
RECRUITING
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Wuhan Central Hospital, Wuhan
NOT_YET_RECRUITING
Wuhan University Zhongnan Hospital, Wuhan
RECRUITING
Xiangyang Central Hospital, Xiangyang
RECRUITING
The First PEOPLE'S HOSPITAL OF CHANGDE CITY, Changde
RECRUITING
Hunan Cancer Hospital, Changsha
RECRUITING
Xiangya Hospital of Central South University, Changsha
RECRUITING
The Central Hospital of Yongzhou, Yongzhou
RECRUITING
Jiangsu Cancer Hospital, Nanjing
RECRUITING
Nanjing Drum Tower Hospital, Nanjing
RECRUITING
The First Affiliated Hospital of Nanjing Medical University, Nanjing
RECRUITING
Xuzhou Central Hospital, Xuzhou
RECRUITING
Jiangxi Cancer Hospital, Nanchang
RECRUITING
Jilin Cancer Hospital, Changchun
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
The Second Hospital of Dalian Medical University, Dalian
NOT_YET_RECRUITING
The First Affiliated Hospital of JINZHOU Medical University, Jinzhou
RECRUITING
Liaoning Cancer Hospital & Institute, Shenyang
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
First Affiliated Hospital of Xian Jiaotong University, Xi'an
RECRUITING
Baoji Central Hospital, Baoji
NOT_YET_RECRUITING
Binzhou Medical University Hospital, Binzhou
RECRUITING
Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
RECRUITING
Linyi Cancer Hospital, Linyi
RECRUITING
Linyi People'S Hostipal, Linyi
RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
RECRUITING
Weifang People'S Hospital, Weifang
RECRUITING
Weihai Municipal Hospital, Weihai
RECRUITING
Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
Shanghai General Hospital, Shanghai
RECRUITING
Sichuan Cancer Hospital, Chengdu
RECRUITING
Tianjin Medical University Cancer Institute & Hospital, Tianjin
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Ningbo Medical Center Lihuili Hospital, Ningbo
Lead Sponsor
Nanjing Zaiming Pharmaceutical Co., Ltd.
INDUSTRY
Jiangsu Simcere Pharmaceutical Co., Ltd.
INDUSTRY